News - Mecwins

News

Revolutionary AVAC technology for ultra-sensitive and high-throughput biomarker detection unveiled!

Revolutionary AVAC technology for ultra-sensitive and high-throughput biomarker detection unveiled!

By mecwins mecwins|2025-02-18T21:21:39+02:0018 February, 2025|News|

At Mecwins, we are excited to share the publication [...]

Comments Off

Mecwins Leads Revolution in Cancer Drug Monitoring

Mecwins Leads Revolution in Cancer Drug Monitoring

By mecwins mecwins|2025-02-14T10:01:57+02:0014 February, 2025|News|

We're excited to announce that Mecwins is playing [...]

Comments Off

Mecwins and Destina Genómica receive CDTI support for an innovative breast cancer early detection project

Mecwins and Destina Genómica receive CDTI support for an innovative breast cancer early detection project

By mecwins mecwins|2025-02-07T09:34:49+02:007 February, 2025|News|

We are thrilled to share some exciting news: Mecwins, [...]

Comments Off

Exploring the Future of Instrumentation at JCTI – Universidad Autónoma de Madrid

Exploring the Future of Instrumentation at JCTI – Universidad Autónoma de Madrid

By mecwins mecwins|2025-02-03T11:29:37+02:003 February, 2025|Mecwins Services, News|

Last Thursday, our CEO Óscar Ahumada and our [...]

Comments Off

Breaking New Ground in Cardiology: Our Experience at “Nano solutions meet big challenges in health”

Breaking New Ground in Cardiology: Our Experience at “Nano solutions meet big challenges in health”

By mecwins mecwins|2025-01-31T15:28:20+02:0031 January, 2025|Mecwins Services, News|

Last week, Mecwins had the opportunity to participate [...]

Comments Off

Mecwins Concludes Successful Participation at Biotech Showcase 2025

Mecwins Concludes Successful Participation at Biotech Showcase 2025

By mecwins mecwins|2025-01-22T09:01:46+02:0022 January, 2025|News|

Mecwins is delighted to announce the successful conclusion of [...]

Comments Off

Mecwins and Universitat Politècnica de Catalunya Publish Major Advances in D-dimer Detection for Thrombosis and COVID-19

Mecwins and Universitat Politècnica de Catalunya Publish Major Advances in D-dimer Detection for Thrombosis and COVID-19

By mecwins mecwins|2025-01-16T10:18:29+02:0016 January, 2025|News|

We are pleased to announce the publication of an [...]

Comments Off

Mecwins to participate in Biotech Showcase 2025, a key event during J.P. Morgan Healthcare Week

Mecwins to participate in Biotech Showcase 2025, a key event during J.P. Morgan Healthcare Week

By mecwins mecwins|2025-01-13T10:11:16+02:0013 January, 2025|News|

Mecwins is pleased to announce that its leadership [...]

Comments Off

Mecwins and University of Teramo research highlighted on the front page of Biosensors

Mecwins and University of Teramo research highlighted on the front page of Biosensors

By mecwins mecwins|2025-01-08T14:30:38+02:008 January, 2025|News|

Biosensors We are [...]

Comments Off

Mecwins celebrates strategic patent grant in China

Mecwins celebrates strategic patent grant in China

By mecwins mecwins|2024-12-16T09:29:16+02:0016 December, 2024|News|

Mecwins is pleased to announce that China's National Intellectual [...]

Comments Off

Address:

Ronda de Poniente, 15. 2ºD
28760 – Tres Cantos – MADRID

Telephone:

+34 918 049 064

Email:

info@mecwins.com

Business

The project “NANO_PROST” (RTC-2016-4776-1) carried out in the period 2016-2018 has been financed by the State Program for Research, Development and Innovation Oriented to the Challenges of Society, within the framework of the State Plan of Scientific and Technical Research and Innovation 2013-2016, of the Ministry of Economy, Industry and Competitiveness.

Project “SPECTRASENS”: Funded by: FEDER / Ministry of Science, Innovation and Universities – State Research Agency / _Project RTC-2017-6311-1.

Banner ministerio

Proyecto CPP2021-008902 financiado por:

Banner ministerio

Proyecto CPP2022-009994 financiado por:

Banner ministerio

Proyecto PLEC2021-007892 financiado por:

Banner ministerio

MIG-20231023 – IMPACT Photonics – Investigación para la Integración de Nuevas Arquitecturas Sensoras de Fotónica Integrada Multiplexada y Terahercios Hiperespectrales para un Sistema Microfluídico In Vitro para Monitorizar Tratamientos Farmacológicos contra el Cáncer

LogoPublicidad CDTI

MIG-20241051 – BIOMULTIDETEC – Nueva Tecnología Biosensora Multi-Analítica para la Detección Temprana de Cáncer de Mama mediante Biopsia Líquida

Next Generation

El contrato es parte de la ayuda DIN2020-011175, financiado por MCIN/AEI/10.13039/501100011033 y por la Unión Europea “NextGenerationEU/PRTR”

El proyecto “NANO_PROST” (RTC-2016-4776-1) llevado a cabo en el período 2016-2018 ha sido financiado por el Programa Estatal de Investigación, Desarrollo e Innovación Orientada a los Retos de la Sociedad, en el marco del Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016, del Ministerio de Economía, Industria y Competitividad.

Proyecto “SPECTRASENS”: Financiado por: FEDER/Ministerio de Ciencia, Innovación y Universidades – Agencia Estatal de Investigación/ _Proyecto RTC-2017-6311-1.

Banner ministerio

Proyecto CPP2021-008902 financiado por

Banner ministerio

Proyecto CPP2022-009994 financiado por

Banner ministerio

Proyecto PLEC2021-007892 financiado por

Banner ministerio

MIG-20231023 – IMPACT Photonics – Investigación para la Integración de Nuevas Arquitecturas Sensoras de Fotónica Integrada Multiplexada y Terahercios Hiperespectrales para un Sistema Microfluídico In Vitro para Monitorizar Tratamientos Farmacológicos contra el Cáncer

LogoPublicidad CDTI

MIG-20241051 – BIOMULTIDETEC – Nueva Tecnología Biosensora Multi-Analítica para la Detección Temprana de Cáncer de Mama mediante Biopsia Líquida

LogoPublicidad CDTI

Next Generation

El contrato es parte de la ayuda DIN2020-011175, financiado por MCIN/AEI/10.13039/501100011033 y por la Unión Europea “NextGenerationEU/PRTR”

Privacy Policy | Cookies Policy | Legal Warning 2025 © Mecwins All rights reserved